+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cardiac Tissue Engineering Market by Product Type (Bioartificial Hearts, Cardiac Patches, Cardiac Scaffolds), Application (Heart Valve Regeneration, Myocardial Repair, Vascular Grafting), Technology, End User, Cell Source - Global Forecast 2025-2030- Product Image
Cardiac Tissue Engineering Market by Product Type (Bioartificial Hearts, Cardiac Patches, Cardiac Scaffolds), Application (Heart Valve Regeneration, Myocardial Repair, Vascular Grafting), Technology, End User, Cell Source - Global Forecast 2025-2030- Product Image
Sale

Cardiac Tissue Engineering Market by Product Type (Bioartificial Hearts, Cardiac Patches, Cardiac Scaffolds), Application (Heart Valve Regeneration, Myocardial Repair, Vascular Grafting), Technology, End User, Cell Source - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 191 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6014766
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Cardiac Tissue Engineering Market presents substantial opportunities for innovation and commercialization, driven by multi-disciplinary advances that are altering treatment landscapes for cardiovascular diseases. Senior leaders in biotech, pharma, and healthcare systems must adapt to evolving technologies and supply chain pressures to maintain competitive differentiation in this rapidly shifting sector.

Market Snapshot: Cardiac Tissue Engineering Sector Growth

The cardiac tissue engineering market expanded from USD 10.45 billion in 2024 to USD 11.37 billion in 2025. With a projected compound annual growth rate (CAGR) of 8.62%, the sector is forecast to reach USD 17.18 billion by 2030. Market momentum is primarily fueled by advancements in biofabrication, stem cell platforms, and the increasing integration of regenerative methodologies across clinical settings.

Scope & Segmentation

This report delivers a targeted analysis of innovations, competitive trends, and commercialization pathways shaping regional and global growth in cardiac tissue engineering. Segmentation spans product types, application areas, technological frameworks, end users, cell sources, and geographic regions, facilitating actionable insights and benchmarking across diverse market drivers.

  • Product Types: Bioartificial Hearts (Partial, Whole), Cardiac Patches (Decellularized, Electrospun), Cardiac Scaffolds (Biological, Synthetic), Injectable Hydrogels (Natural, Synthetic)
  • Application Domains: Heart Valve Regeneration (Biological Valve Regeneration, Mechanical Valve Replacement), Myocardial Repair (Congenital Defect Repair, Post Infarction Repair), Vascular Grafting (Coronary Artery Bypass, Peripheral Vascular Repair)
  • Technologies: 3D Bioprinting (Extrusion Based, Inkjet Based, Laser Assisted), Decellularized Matrices (Tissue Segment, Whole Organ), Stem Cell Therapy (Embryonic, Induced Pluripotent, Mesenchymal)
  • End Users: Biotechnology Companies, Hospitals, Pharmaceutical Companies, Research Institutes
  • Cell Sources: Allogeneic (Donor Cardiomyocytes, Donor Stromal Cells), Autologous (Cardiomyocytes, Stromal Cells), Xenogeneic (Bovine, Porcine Cells)
  • Regions: Americas (including the United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (notably the United Kingdom, Germany, France, Russia, United Arab Emirates, and more), Asia-Pacific (with focus on China, India, Japan, Australia, and Southeast Asian countries)

Key Takeaways for Senior Stakeholders

  • Cardiac tissue engineering is rapidly evolving through cross-disciplinary collaborations, allowing clinical, academic, and industry stakeholders to accelerate new regenerative solutions.
  • Integration of artificial intelligence and digital twin modeling is enabling design optimization and more predictable manufacturing outcomes, enhancing scalability and product reliability.
  • New regulatory frameworks are providing expedited pathways for clinical adoption of innovative therapies, as authorities increasingly adapt to the needs of advanced regenerative constructs.
  • Strategic partnerships across hospital networks, biotechnology innovators, and pharmaceutical companies are accelerating the translation of early-stage research into targeted patient solutions.
  • Investment in regional manufacturing clusters and contract development organizations is helping to address supply chain vulnerabilities and ensure consistent quality for rapidly advancing therapeutic applications.

Tariff Impact: Navigating U.S. Trade Policy in Cardiac Tissue Engineering

The introduction of new United States tariffs in 2025 is reshaping procurement strategies and highlighting the necessity for supply chain resilience. Organizations are increasingly diversifying their supplier base, investing in domestic manufacturing expansion, and adopting open-source hardware to mitigate elevated input costs. These measures are fostering regional innovation and supporting the development of alternatives less reliant on imported bioreactors and specialized biomaterials. Active industry consortia engagement is advocating for tariff exemptions for essential research materials, positioning the sector to adapt while supporting sustainable growth.

Methodology & Data Sources

Research is grounded in a balanced mix of secondary and primary approaches. Comprehensive reviews of journals, patent filings, regulatory documents, and clinical trial data provide foundational knowledge. Expert interviews with stakeholders from academia, biotechnology, clinical practice, and regulatory affairs ensure nuanced insights on market dynamics and evolving requirements for cardiac tissue engineering solutions. Findings are validated through multi-source triangulation and iterative subject matter expert review.

Why This Report Matters

  • Enables executives and investment teams to benchmark innovation and commercialization trends in cardiac tissue engineering, supporting strategic planning and early risk identification.
  • Provides structured segmentation and regional analysis, allowing for precise resource allocation and targeted partnership formation aligned with technology readiness and market access.
  • Equips stakeholders with evidence-driven recommendations for investment, regulatory engagement, and adoption of flexible manufacturing and collaborative R&D models.

Conclusion

As cardiac tissue engineering advances, organizations equipped with granular market insights can maximize translational impact and drive sustained growth. Collaborations, agility in supply strategies, and early regulatory alignment remain critical for capturing value in this rapidly evolving sector.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Advances in 3D bioprinting of vascularized cardiac patches for patient-specific therapy
5.2. Integration of microfluidic heart-on-a-chip platforms for high-throughput cardiotoxicity screening
5.3. Development of decellularized extracellular matrix scaffolds for improved cardiac tissue regeneration
5.4. Use of human induced pluripotent stem cell-derived cardiomyocytes for personalized disease modeling
5.5. Implementation of injectable hydrogel systems delivering bioactive molecules to injured myocardium
5.6. Application of CRISPR gene editing within engineered cardiac constructs to correct genetic cardiomyopathies
5.7. Adoption of artificial intelligence algorithms for predictive modeling of engineered heart tissue maturation
5.8. Commercial scale-up challenges in manufacturing reproducible cardiac tissue patches under GMP conditions
5.9. Emerging clinical trial outcomes of bioengineered myocardial grafts in heart failure patients
5.10. Integration of angiogenic growth factor delivery within engineered cardiac constructs for neovascularization
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Cardiac Tissue Engineering Market, by Product Type
8.1. Introduction
8.2. Bioartificial Hearts
8.2.1. Partial Hearts
8.2.2. Whole Hearts
8.3. Cardiac Patches
8.3.1. Decellularized Patches
8.3.2. Electrospun Patches
8.4. Cardiac Scaffolds
8.4.1. Biological Scaffolds
8.4.2. Synthetic Scaffolds
8.5. Injectable Hydrogels
8.5.1. Natural Hydrogels
8.5.2. Synthetic Hydrogels
9. Cardiac Tissue Engineering Market, by Application
9.1. Introduction
9.2. Heart Valve Regeneration
9.2.1. Biological Valve Regeneration
9.2.2. Mechanical Valve Replacement
9.3. Myocardial Repair
9.3.1. Congenital Defect Repair
9.3.2. Post Infarction Repair
9.4. Vascular Grafting
9.4.1. Coronary Artery Bypass
9.4.2. Peripheral Vascular Repair
10. Cardiac Tissue Engineering Market, by Technology
10.1. Introduction
10.2. 3D Bioprinting
10.2.1. Extrusion Based
10.2.2. Inkjet Based
10.2.3. Laser Assisted
10.3. Decellularized Matrices
10.3.1. Tissue Segment Decellularization
10.3.2. Whole Organ Decellularization
10.4. Stem Cell Therapy
10.4.1. Embryonic Stem Cells
10.4.2. Induced Pluripotent Stem Cells
10.4.3. Mesenchymal Stem Cells
11. Cardiac Tissue Engineering Market, by End User
11.1. Introduction
11.2. Biotechnology Companies
11.3. Hospitals
11.4. Pharmaceutical Companies
11.5. Research Institutes
12. Cardiac Tissue Engineering Market, by Cell Source
12.1. Introduction
12.2. Allogeneic
12.2.1. Donor Cardiomyocytes
12.2.2. Donor Stromal Cells
12.3. Autologous
12.3.1. Cardiomyocytes
12.3.2. Stromal Cells
12.4. Xenogeneic
12.4.1. Bovine Cells
12.4.2. Porcine Cells
13. Americas Cardiac Tissue Engineering Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Cardiac Tissue Engineering Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Cardiac Tissue Engineering Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Organovo Holdings, Inc.
16.3.2. Tara Biosystems, Inc.
16.3.3. InSphero AG
16.3.4. Ncardia B.V.
16.3.5. NovoHeart, Inc.
16.3.6. BioCardia, Inc.
16.3.7. BICO Group AB
16.3.8. Matricelf, Inc.
16.3.9. XylyxBio LLC
16.3.10. AxoSim, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. CARDIAC TISSUE ENGINEERING MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CELL SOURCE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CELL SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC CARDIAC TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC CARDIAC TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. CARDIAC TISSUE ENGINEERING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. CARDIAC TISSUE ENGINEERING MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. CARDIAC TISSUE ENGINEERING MARKET: RESEARCHAI
FIGURE 26. CARDIAC TISSUE ENGINEERING MARKET: RESEARCHSTATISTICS
FIGURE 27. CARDIAC TISSUE ENGINEERING MARKET: RESEARCHCONTACTS
FIGURE 28. CARDIAC TISSUE ENGINEERING MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. CARDIAC TISSUE ENGINEERING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY BIOARTIFICIAL HEARTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY BIOARTIFICIAL HEARTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY PARTIAL HEARTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY PARTIAL HEARTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY WHOLE HEARTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY WHOLE HEARTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY BIOARTIFICIAL HEARTS, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY BIOARTIFICIAL HEARTS, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC PATCHES, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC PATCHES, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY DECELLULARIZED PATCHES, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY DECELLULARIZED PATCHES, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY ELECTROSPUN PATCHES, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY ELECTROSPUN PATCHES, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC PATCHES, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC PATCHES, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC SCAFFOLDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC SCAFFOLDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY BIOLOGICAL SCAFFOLDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY BIOLOGICAL SCAFFOLDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY SYNTHETIC SCAFFOLDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY SYNTHETIC SCAFFOLDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC SCAFFOLDS, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC SCAFFOLDS, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY INJECTABLE HYDROGELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY INJECTABLE HYDROGELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY NATURAL HYDROGELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY NATURAL HYDROGELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY SYNTHETIC HYDROGELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY SYNTHETIC HYDROGELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY INJECTABLE HYDROGELS, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY INJECTABLE HYDROGELS, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY HEART VALVE REGENERATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY HEART VALVE REGENERATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY BIOLOGICAL VALVE REGENERATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY BIOLOGICAL VALVE REGENERATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY MECHANICAL VALVE REPLACEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY MECHANICAL VALVE REPLACEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY HEART VALVE REGENERATION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY HEART VALVE REGENERATION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY MYOCARDIAL REPAIR, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY MYOCARDIAL REPAIR, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CONGENITAL DEFECT REPAIR, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CONGENITAL DEFECT REPAIR, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY POST INFARCTION REPAIR, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY POST INFARCTION REPAIR, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY MYOCARDIAL REPAIR, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY MYOCARDIAL REPAIR, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY VASCULAR GRAFTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY VASCULAR GRAFTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CORONARY ARTERY BYPASS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CORONARY ARTERY BYPASS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY PERIPHERAL VASCULAR REPAIR, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY PERIPHERAL VASCULAR REPAIR, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY VASCULAR GRAFTING, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY VASCULAR GRAFTING, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY 3D BIOPRINTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY 3D BIOPRINTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY EXTRUSION BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY EXTRUSION BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY INKJET BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY INKJET BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY LASER ASSISTED, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY LASER ASSISTED, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY 3D BIOPRINTING, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY 3D BIOPRINTING, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY DECELLULARIZED MATRICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY DECELLULARIZED MATRICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY TISSUE SEGMENT DECELLULARIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY TISSUE SEGMENT DECELLULARIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY WHOLE ORGAN DECELLULARIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY WHOLE ORGAN DECELLULARIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY DECELLULARIZED MATRICES, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY DECELLULARIZED MATRICES, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY STEM CELL THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY STEM CELL THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY EMBRYONIC STEM CELLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY EMBRYONIC STEM CELLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY MESENCHYMAL STEM CELLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY MESENCHYMAL STEM CELLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY STEM CELL THERAPY, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY STEM CELL THERAPY, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CELL SOURCE, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CELL SOURCE, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY ALLOGENEIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY ALLOGENEIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY DONOR CARDIOMYOCYTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY DONOR CARDIOMYOCYTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY DONOR STROMAL CELLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY DONOR STROMAL CELLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY ALLOGENEIC, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY ALLOGENEIC, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY AUTOLOGOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY AUTOLOGOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIOMYOCYTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIOMYOCYTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY STROMAL CELLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY STROMAL CELLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY AUTOLOGOUS, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY AUTOLOGOUS, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY XENOGENEIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY XENOGENEIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY BOVINE CELLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY BOVINE CELLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY PORCINE CELLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY PORCINE CELLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 133. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY XENOGENEIC, 2018-2024 (USD MILLION)
TABLE 134. GLOBAL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY XENOGENEIC, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY BIOARTIFICIAL HEARTS, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY BIOARTIFICIAL HEARTS, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC PATCHES, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC PATCHES, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC SCAFFOLDS, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC SCAFFOLDS, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY INJECTABLE HYDROGELS, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY INJECTABLE HYDROGELS, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY HEART VALVE REGENERATION, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY HEART VALVE REGENERATION, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY MYOCARDIAL REPAIR, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY MYOCARDIAL REPAIR, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY VASCULAR GRAFTING, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY VASCULAR GRAFTING, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 155. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY 3D BIOPRINTING, 2018-2024 (USD MILLION)
TABLE 156. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY 3D BIOPRINTING, 2025-2030 (USD MILLION)
TABLE 157. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY DECELLULARIZED MATRICES, 2018-2024 (USD MILLION)
TABLE 158. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY DECELLULARIZED MATRICES, 2025-2030 (USD MILLION)
TABLE 159. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY STEM CELL THERAPY, 2018-2024 (USD MILLION)
TABLE 160. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY STEM CELL THERAPY, 2025-2030 (USD MILLION)
TABLE 161. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 162. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 163. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CELL SOURCE, 2018-2024 (USD MILLION)
TABLE 164. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CELL SOURCE, 2025-2030 (USD MILLION)
TABLE 165. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY ALLOGENEIC, 2018-2024 (USD MILLION)
TABLE 166. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY ALLOGENEIC, 2025-2030 (USD MILLION)
TABLE 167. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY AUTOLOGOUS, 2018-2024 (USD MILLION)
TABLE 168. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY AUTOLOGOUS, 2025-2030 (USD MILLION)
TABLE 169. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY XENOGENEIC, 2018-2024 (USD MILLION)
TABLE 170. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY XENOGENEIC, 2025-2030 (USD MILLION)
TABLE 171. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 172. AMERICAS CARDIAC TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY BIOARTIFICIAL HEARTS, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY BIOARTIFICIAL HEARTS, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC PATCHES, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC PATCHES, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC SCAFFOLDS, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC SCAFFOLDS, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY INJECTABLE HYDROGELS, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY INJECTABLE HYDROGELS, 2025-2030 (USD MILLION)
TABLE 183. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 184. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 185. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY HEART VALVE REGENERATION, 2018-2024 (USD MILLION)
TABLE 186. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY HEART VALVE REGENERATION, 2025-2030 (USD MILLION)
TABLE 187. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY MYOCARDIAL REPAIR, 2018-2024 (USD MILLION)
TABLE 188. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY MYOCARDIAL REPAIR, 2025-2030 (USD MILLION)
TABLE 189. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY VASCULAR GRAFTING, 2018-2024 (USD MILLION)
TABLE 190. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY VASCULAR GRAFTING, 2025-2030 (USD MILLION)
TABLE 191. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 192. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 193. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY 3D BIOPRINTING, 2018-2024 (USD MILLION)
TABLE 194. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY 3D BIOPRINTING, 2025-2030 (USD MILLION)
TABLE 195. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY DECELLULARIZED MATRICES, 2018-2024 (USD MILLION)
TABLE 196. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY DECELLULARIZED MATRICES, 2025-2030 (USD MILLION)
TABLE 197. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY STEM CELL THERAPY, 2018-2024 (USD MILLION)
TABLE 198. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY STEM CELL THERAPY, 2025-2030 (USD MILLION)
TABLE 199. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 200. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 201. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CELL SOURCE, 2018-2024 (USD MILLION)
TABLE 202. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CELL SOURCE, 2025-2030 (USD MILLION)
TABLE 203. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY ALLOGENEIC, 2018-2024 (USD MILLION)
TABLE 204. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY ALLOGENEIC, 2025-2030 (USD MILLION)
TABLE 205. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY AUTOLOGOUS, 2018-2024 (USD MILLION)
TABLE 206. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY AUTOLOGOUS, 2025-2030 (USD MILLION)
TABLE 207. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY XENOGENEIC, 2018-2024 (USD MILLION)
TABLE 208. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY XENOGENEIC, 2025-2030 (USD MILLION)
TABLE 209. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 210. UNITED STATES CARDIAC TISSUE ENGINEERING MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 211. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 212. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 213. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY BIOARTIFICIAL HEARTS, 2018-2024 (USD MILLION)
TABLE 214. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY BIOARTIFICIAL HEARTS, 2025-2030 (USD MILLION)
TABLE 215. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC PATCHES, 2018-2024 (USD MILLION)
TABLE 216. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC PATCHES, 2025-2030 (USD MILLION)
TABLE 217. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC SCAFFOLDS, 2018-2024 (USD MILLION)
TABLE 218. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC SCAFFOLDS, 2025-2030 (USD MILLION)
TABLE 219. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY INJECTABLE HYDROGELS, 2018-2024 (USD MILLION)
TABLE 220. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY INJECTABLE HYDROGELS, 2025-2030 (USD MILLION)
TABLE 221. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 222. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 223. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY HEART VALVE REGENERATION, 2018-2024 (USD MILLION)
TABLE 224. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY HEART VALVE REGENERATION, 2025-2030 (USD MILLION)
TABLE 225. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY MYOCARDIAL REPAIR, 2018-2024 (USD MILLION)
TABLE 226. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY MYOCARDIAL REPAIR, 2025-2030 (USD MILLION)
TABLE 227. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY VASCULAR GRAFTING, 2018-2024 (USD MILLION)
TABLE 228. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY VASCULAR GRAFTING, 2025-2030 (USD MILLION)
TABLE 229. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 230. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 231. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY 3D BIOPRINTING, 2018-2024 (USD MILLION)
TABLE 232. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY 3D BIOPRINTING, 2025-2030 (USD MILLION)
TABLE 233. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY DECELLULARIZED MATRICES, 2018-2024 (USD MILLION)
TABLE 234. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY DECELLULARIZED MATRICES, 2025-2030 (USD MILLION)
TABLE 235. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY STEM CELL THERAPY, 2018-2024 (USD MILLION)
TABLE 236. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY STEM CELL THERAPY, 2025-2030 (USD MILLION)
TABLE 237. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 238. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 239. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CELL SOURCE, 2018-2024 (USD MILLION)
TABLE 240. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CELL SOURCE, 2025-2030 (USD MILLION)
TABLE 241. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY ALLOGENEIC, 2018-2024 (USD MILLION)
TABLE 242. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY ALLOGENEIC, 2025-2030 (USD MILLION)
TABLE 243. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY AUTOLOGOUS, 2018-2024 (USD MILLION)
TABLE 244. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY AUTOLOGOUS, 2025-2030 (USD MILLION)
TABLE 245. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY XENOGENEIC, 2018-2024 (USD MILLION)
TABLE 246. CANADA CARDIAC TISSUE ENGINEERING MARKET SIZE, BY XENOGENEIC, 2025-2030 (USD MILLION)
TABLE 247. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 248. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 249. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY BIOARTIFICIAL HEARTS, 2018-2024 (USD MILLION)
TABLE 250. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY BIOARTIFICIAL HEARTS, 2025-2030 (USD MILLION)
TABLE 251. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC PATCHES, 2018-2024 (USD MILLION)
TABLE 252. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC PATCHES, 2025-2030 (USD MILLION)
TABLE 253. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC SCAFFOLDS, 2018-2024 (USD MILLION)
TABLE 254. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC SCAFFOLDS, 2025-2030 (USD MILLION)
TABLE 255. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY INJECTABLE HYDROGELS, 2018-2024 (USD MILLION)
TABLE 256. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY INJECTABLE HYDROGELS, 2025-2030 (USD MILLION)
TABLE 257. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 258. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 259. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY HEART VALVE REGENERATION, 2018-2024 (USD MILLION)
TABLE 260. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY HEART VALVE REGENERATION, 2025-2030 (USD MILLION)
TABLE 261. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY MYOCARDIAL REPAIR, 2018-2024 (USD MILLION)
TABLE 262. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY MYOCARDIAL REPAIR, 2025-2030 (USD MILLION)
TABLE 263. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY VASCULAR GRAFTING, 2018-2024 (USD MILLION)
TABLE 264. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY VASCULAR GRAFTING, 2025-2030 (USD MILLION)
TABLE 265. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 266. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 267. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY 3D BIOPRINTING, 2018-2024 (USD MILLION)
TABLE 268. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY 3D BIOPRINTING, 2025-2030 (USD MILLION)
TABLE 269. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY DECELLULARIZED MATRICES, 2018-2024 (USD MILLION)
TABLE 270. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY DECELLULARIZED MATRICES, 2025-2030 (USD MILLION)
TABLE 271. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY STEM CELL THERAPY, 2018-2024 (USD MILLION)
TABLE 272. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY STEM CELL THERAPY, 2025-2030 (USD MILLION)
TABLE 273. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 274. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 275. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CELL SOURCE, 2018-2024 (USD MILLION)
TABLE 276. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CELL SOURCE, 2025-2030 (USD MILLION)
TABLE 277. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY ALLOGENEIC, 2018-2024 (USD MILLION)
TABLE 278. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY ALLOGENEIC, 2025-2030 (USD MILLION)
TABLE 279. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY AUTOLOGOUS, 2018-2024 (USD MILLION)
TABLE 280. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY AUTOLOGOUS, 2025-2030 (USD MILLION)
TABLE 281. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY XENOGENEIC, 2018-2024 (USD MILLION)
TABLE 282. MEXICO CARDIAC TISSUE ENGINEERING MARKET SIZE, BY XENOGENEIC, 2025-2030 (USD MILLION)
TABLE 283. BRAZIL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 284. BRAZIL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 285. BRAZIL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY BIOARTIFICIAL HEARTS, 2018-2024 (USD MILLION)
TABLE 286. BRAZIL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY BIOARTIFICIAL HEARTS, 2025-2030 (USD MILLION)
TABLE 287. BRAZIL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC PATCHES, 2018-2024 (USD MILLION)
TABLE 288. BRAZIL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC PATCHES, 2025-2030 (USD MILLION)
TABLE 289. BRAZIL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC SCAFFOLDS, 2018-2024 (USD MILLION)
TABLE 290. BRAZIL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY CARDIAC SCAFFOLDS, 2025-2030 (USD MILLION)
TABLE 291. BRAZIL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY INJECTABLE HYDROGELS, 2018-2024 (USD MILLION)
TABLE 292. BRAZIL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY INJECTABLE HYDROGELS, 2025-2030 (USD MILLION)
TABLE 293. BRAZIL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 294. BRAZIL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 295. BRAZIL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY HEART VALVE REGENERATION, 2018-2024 (USD MILLION)
TABLE 296. BRAZIL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY HEART VALVE REGENERATION, 2025-2030 (USD MILLION)
TABLE 297. BRAZIL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY MYOCARDIAL REPAIR, 2018-2024 (USD MILLION)
TABLE 298. BRAZIL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY MYOCARDIAL REPAIR, 2025-2030 (USD MILLION)
TABLE 299. BRAZIL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY VASCULAR GRAFTING, 2018-2024 (USD MILLION)
TABLE 300. BRAZIL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY VASCULAR GRAFTING, 2025-2030 (USD MILLION)
TABLE 301. BRAZIL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 302. BRAZIL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 303. BRAZIL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY 3D BIOPRINTING, 2018-2024 (USD MILLION)
TABLE 304. BRAZIL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY 3D BIOPRINTING, 2025-2030 (USD MILLION)
TABLE 305. BRAZIL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY DECELLULARIZED MATRICES, 2018-2024 (USD MILLION)
TABLE 306. BRAZIL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY DECELLULARIZED MATRICES, 2025-2030 (USD MILLION)
TABLE 307. BRAZIL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY STEM CELL THERAPY, 2018-2024 (USD MILLION)
TABLE 308. BRAZIL CARDIAC TISSUE ENGINEERING MARKET SIZE, BY STEM CEL

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Cardiac Tissue Engineering market report include:
  • Organovo Holdings, Inc.
  • Tara Biosystems, Inc.
  • InSphero AG
  • Ncardia B.V.
  • NovoHeart, Inc.
  • BioCardia, Inc.
  • BICO Group AB
  • Matricelf, Inc.
  • XylyxBio LLC
  • AxoSim, Inc.

Table Information

Report AttributeDetails
No. of Pages191
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 11.37 Billion
Forecasted Market Value ( USD ) by 2030 $ 17.18 Billion
Compound Annual Growth Rate8.6%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Cardiac Tissue Engineering Market Size, Share & Trends by Material (Scaffold, Stem Cells), Product (Heart Valve, Vascular Grafts), Applications (MI,Congenital Heart Disease), End-user (Hospitals & Clinics, Academics & Research Institutes) - Global Forecast to 2029 - Product Image

Cardiac Tissue Engineering Market Size, Share & Trends by Material (Scaffold, Stem Cells), Product (Heart Valve, Vascular Grafts), Applications (MI,Congenital Heart Disease), End-user (Hospitals & Clinics, Academics & Research Institutes) - Global Forecast to 2029

  • Report
  • 337 Pages
  • Global
From
Cardiac Tissue Engineering Global Market Report 2025 - Product Image

Cardiac Tissue Engineering Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Live Cell Encapsulation Market by Application (Cell Therapy, Diabetes Management, Drug Delivery), Technology (Macroencapsulation, Microencapsulation), Material, End User, Cell Type - Global Forecast 2025-2030 - Product Image

Live Cell Encapsulation Market by Application (Cell Therapy, Diabetes Management, Drug Delivery), Technology (Macroencapsulation, Microencapsulation), Material, End User, Cell Type - Global Forecast 2025-2030

  • Report
  • 188 Pages
  • Global
From
Tissue Engineering Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Tissue Engineering Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From
Extracellular Matrix (ECM) Patches - Global Strategic Business Report - Product Image

Extracellular Matrix (ECM) Patches - Global Strategic Business Report

  • Report
  • 288 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.